INVO Bioscience Inc (INVO)
0.92
-0.02
(-2.31%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 18:47
INVO Bioscience Revenue (TTM): 3.021M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.021M |
September 30, 2023 | 1.917M |
June 30, 2023 | 1.177M |
March 31, 2023 | 1.008M |
December 31, 2022 | 0.8222M |
September 30, 2022 | 3.592M |
June 30, 2022 | 3.576M |
March 31, 2022 | 3.638M |
December 31, 2021 | 4.160M |
September 30, 2021 | 1.308M |
June 30, 2021 | 1.426M |
March 31, 2021 | 1.463M |
December 31, 2020 | 1.037M |
September 30, 2020 | 1.169M |
June 30, 2020 | 1.137M |
March 31, 2020 | 1.549M |
December 31, 2019 | 1.480M |
September 30, 2019 | 1.307M |
June 30, 2019 | 1.128M |
March 31, 2019 | 0.5797M |
December 31, 2018 | 0.4944M |
September 30, 2018 | 0.4207M |
June 30, 2018 | 0.3639M |
Date | Value |
---|---|
March 31, 2018 | 0.334M |
December 31, 2017 | 0.2821M |
September 30, 2017 | 0.2103M |
June 30, 2017 | 0.1599M |
March 31, 2017 | 0.085M |
December 31, 2016 | 0.0509M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | 0.0155M |
June 30, 2015 | 0.0258M |
March 31, 2015 | 0.0421M |
December 31, 2011 | 0.0715M |
September 30, 2011 | 0.0974M |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | 0.0478M |
March 31, 2010 | 0.0532M |
December 31, 2009 | 0.0632M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.8222M
Minimum
Dec 2022
4.160M
Maximum
Dec 2021
1.890M
Average
1.426M
Median
Jun 2021
Revenue (TTM) Benchmarks
Abbott Laboratories | 40.33B |
Perspective Therapeutics Inc | 0.00 |
Xtant Medical Holdings Inc | 91.30M |
Asensus Surgical Inc | 8.577M |
Catheter Precision Inc | 0.442M |